Rosetta Inpharmatics' Unattributed VC - II Round

Rosetta Inpharmatics raised a round of funding on October 08, 1999. Investors include Agilent Ventures.

Rosetta Inpharmatics, a wholly owned subsidiary of Merck and Co. Inc., develops and implements technologies that will improve drug discovery.…

Articles about Rosetta Inpharmatics' Unattributed VC - II Round: